New vaccine aims to stop rare but deadly brain infections
NCT ID NCT06899802
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 23 times
Summary
This study tests a new vaccine designed to protect people from two viruses (VEEV and EEEV) that can cause severe brain swelling (encephalitis). About 411 healthy adults aged 18-50 will receive different doses of the vaccine or a placebo to find the safest and most effective dose. The goal is to see if the vaccine triggers a strong immune response and is well-tolerated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benchmark Research
Sacramento, California, 95864, United States
-
Benchmark Research
Kenner, Louisiana, 70065, United States
-
Benchmark Research
San Angelo, Texas, 76904, United States
-
Clay-Platte Family Medicine, P.C./CCT Research
Kansas City, Missouri, 64151, United States
-
Jefferson City Medical Group / Avacare
Jefferson City, Missouri, 65109, United States
-
Johnson County Clin-Trials
Lenexa, Kansas, 66219, United States
-
Lifeline Primary Care, Inc. / CCT Research
Lilburn, Georgia, 30047, United States
-
Papillion Research Center/CCT Research
Papillion, Nebraska, 68046, United States
-
Versailles Family Medicine, PLLC/CCT Research
Versailles, Kentucky, 40383, United States
Conditions
Explore the condition pages connected to this study.